Gamaleya national research center of epidemiology and microbiology - Latest News Update, Information, Photos & Videos on Gamaleya national research center of epidemiology and microbiology at Lokmat Times

The first batch of the Sputnik V vaccine against COVID-19, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional deliveries are planned in the nearest future, the Russian Health Ministry informs."The first batch of the 'Gam-COVID-Vac' [Sputnik V] vaccine for the prevention of the new coronavirus infection, developed by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has passed the necessary quality tests in the laboratories of Roszdravnadzor [medical device regulator] and has been released into civil circulation," the ministry said in a statement.The Russian health ministry registered the first vaccine against COVID-19, named Sputnik V, on August 11.Moscow Mayor Sergey Sobyn expressed hope on Sunday that the majority of the Russian capital's residents would be vaccinated against the coronavirus within several months.According to the health ministry, the delivery of the first batches of the Russian vaccine to the country's regions is planned in the nearest future. (/Sputnik)( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Gamaleya National Research Center Of Epidemiology And MicrobiologyFOLLOW

Gamaleya national research center of epidemiology and microbiology, Latest News

Gamaleya National Research Center of Epidemiology and Microbiology on Wednesday said that Sputnik V demonstrated strong protection against Omicron variant of COVID-19. ...

New Delhi, Jan 20 The Sputnik V vaccine has demonstrated strong protection against Omicron variant, with over 2 ... ...

Patients infected with the Omicron variant of COVID-19, who arrived in Russia from South Africa, were earlier vaccinated, their disease is mild, Alexander Gintsburg, director of Russia's Gamaleya National Research Center of Epidemiology and Microbiol ...

Patients infected with the Omicron variant of COVID-19, who arrived in Russia from South Africa, were earlier vaccinated, their disease is mild, Alexander Gintsburg, director of Russia's Gamaleya National Research Center of Epidemiology and Microbiol ...

Moscow, June 27 The first batch of the single-dose Sputnik Light vaccine will soon be administered to civil ... ...

With Russia approaching India for phase 3 trials of its Sputnik V vaccine against COVID-19 and for its manufacture in the country, NITI Aayog member Dr VK Paul said on Tuesday that the government attaches "great importance to this offer of partnershi ...

With Russia approaching India for phase 3 trials of its Sputnik V vaccine against COVID-19 and for its manufacture in the country, NITI Aayog member Dr VK Paul said on Tuesday that the government attaches "great importance to this offer of partnershi ...

The first batch of the Sputnik V vaccine against COVID-19, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional deliv ...